Kentucky Derby winner Medina Spirit’s positive post-race drug test has been confirmed, according to trainer Bob Baffert’s attorney Craig Robertson.
For Many Workers, Change in Mask Policy Is a Nightmare
After a shift by the C.D.C., employers withdrew mask policies that workers felt were protecting them from unvaccinated customers.
Mental Health Is on Sloane Stephens’s Mind, Too
“I should have asked to go to my grandparents’ funeral,” she said. “It’s something that I’ll probably regret for the rest of my life.”
Microsoft Surface Pro X slashed by $300 at Staples in early Prime Day deal
Microsoft’s Surface Pro is a wonderful blend of a tablet and laptop, and it’s packing powerful hardware under the hood and the full Windows 10 experience.
Covid origins mystery continues to spark speculation and tension
The coronavirus SARS-CoV-2 has scorched its way across the world killing millions and bringing economies to a standstill. But where exactly did it come from?
The major Windows 10 redesign could finally be announced at June 24 event
After months of rumors, Microsoft officially set to host an event on June 24 which is all about detailing “what’s next for Windows.”
Israel to expand COVID jab rollout to 12-15 age group
Israel’s health ministry announced Wednesday that children aged 12-15 would be able to receive coronavirus vaccinations, despite “a possible link” between Pfizer/BioNTech inoculations and myocarditis among young men.
France widens COVID vaccine drive to 12 to 18-year-olds
France will start offering COVID-19 vaccines to everyone between 12 and 18 on June 15, President Emmanuel Macron said Wednesday.
German biotech company MorphoSys buys US rival for $1.7B
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
Vaccine protection may diminish need for yearly boosters
Scientists have found clues that the world’s leading COVID-19 vaccines offer lasting protection that could diminish the need for frequent booster shots, but they caution that more research is needed and that virus mutations are still a wild card.